Literature DB >> 17114197

Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.

M McIlveen1, J D Skull, W L Ledger.   

Abstract

BACKGROUND: Unexpectedly poor response leading to IVF cycle cancellation is a distressing treatment outcome. We have prospectively assessed several markers of ovarian reserve in a high risk IVF population to determine their utility in predicting IVF cycle cancellation.
METHODS: Eighty-four women at high risk of cycle cancellation due to raised FSH, previous poor response and/or age > or =40 years attending for high-dose short protocol IVF treatment had baseline measures of FSH, inhibin B, anti-Müllerian hormone (AMH), antral follicle count (AFC) and ovarian volume. A GnRH agonist was then administered and, 24 h later, estradiol (E(2)) and inhibin B measures were repeated.
RESULTS: Fifty-seven per cent of patients in this study had a poor response to stimulation, and 15% were cancelled. Using multivariate logistic regression, we found that day 3 inhibin B levels were the best predictor of cycle cancellation with an area under the receiver operating curve (ROC AUC) = 0.78 (P = 0.017). When only considering baseline variables, mean ovarian volume was the best predictor of cycle cancellation (ROC AUC = 0.78; P = 0.016). AMH concentrations were the best predictor of a poor response (P = 0.003), and AMH was also predictive of cycle cancellation (P = 0.007) with very little inter-cycle variability. None of the parameters studied were predictive of ongoing pregnancy.
CONCLUSIONS: This group of at-risk patients had a high rate of poor response to simulation and cancellation. Although several measures of ovarian reserve were able to predict cycle cancellation, none were able to predict pregnancy. AMH was predictive of both cycle cancellation and poor response with little inter-cycle variability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114197     DOI: 10.1093/humrep/del435

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  20 in total

Review 1.  Ovarian reserve evaluation: state of the art.

Authors:  Bruno Ramalho de Carvalho; Ana Carolina Japur de Sá Rosa e Silva; Júlio César Rosa e Silva; Rosana Maria dos Reis; Rui Alberto Ferriani; Marcos Felipe Silva de Sá
Journal:  J Assist Reprod Genet       Date:  2008-08-05       Impact factor: 3.412

2.  Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Authors:  Mehmet Firat Mutlu; Mehmet Erdem; Ahmet Erdem; Sule Yildiz; Ilknur Mutlu; Ozgur Arisoy; Mesut Oktem
Journal:  J Assist Reprod Genet       Date:  2013-03-19       Impact factor: 3.412

3.  Quantification of anti-Müllerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve.

Authors:  Thomas W McDade; Teresa K Woodruff; Yuan-yen Huang; William E Funk; Maureen Prewitt; Laxmi Kondapalli; Clarisa R Gracia
Journal:  Hum Reprod       Date:  2012-06-06       Impact factor: 6.918

4.  Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

Authors:  Cheng-Hsuan Wu; Yu-Ching Chen; Hsin-Hung Wu; Jyuer-Ger Yang; Yu-Jun Chang; Horng-Der Tsai
Journal:  J Assist Reprod Genet       Date:  2009-07       Impact factor: 3.412

5.  Body size affects measures of ovarian reserve in late reproductive age women.

Authors:  H Irene Su; Mary D Sammel; Ellen W Freeman; Hui Lin; Tracey DeBlasis; Clarisa R Gracia
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

6.  The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET).

Authors:  Wen-Qin Lin; Ling-Nv Yao; Dong-Xue Zhang; Wei Zhang; Xiao-Jing Yang; Rong Yu
Journal:  J Assist Reprod Genet       Date:  2013-03-17       Impact factor: 3.412

7.  Evaluation of ovarian reserve in infertile patients.

Authors:  Mehmet Fırat Mutlu; Ahmet Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

8.  Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve.

Authors:  Dharmawijaya N Lekamge; Michelle Lane; Robert B Gilchrist; Kelton P Tremellen
Journal:  J Assist Reprod Genet       Date:  2008-10-30       Impact factor: 3.412

Review 9.  The role of anti-Müllerian hormone (AMH) in ovarian disease and infertility.

Authors:  Jure Bedenk; Eda Vrtačnik-Bokal; Irma Virant-Klun
Journal:  J Assist Reprod Genet       Date:  2019-11-21       Impact factor: 3.412

10.  Effects of localisation of uterine adenomyosis on outcome of in vitro fertilisation/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study.

Authors:  Takuya Iwasawa; Toshifumi Takahashi; Eri Maeda; Koichi Ishiyama; Satoshi Takahashi; Ryota Suganuma; Koki Matsuo; Masahito Tachibana; Rie Fukuhara; Hiromitsu Shirasawa; Wataru Sato; Yukiyo Kumazawa; Yukihiro Terada
Journal:  Reprod Biol Endocrinol       Date:  2021-06-04       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.